Biologics often represent the cutting-edge of biomedical research and may offer the most effective means to treat a variety of medical illnesses and conditions that presently have no other treatments available. Biologics such as vaccines, plasma-derived products, recombinant products, monoclonal antibodies, cell and gene therapy products are derived from living organisms, so they are quite different from chemically synthesized drugs. Most biologics are not easily identified or characterized and cannot be completely defined in physical and/or chemical terms alone. Because of characteristics of biologics, there is an increased risk of the introduction of adventitious agents. Biologics tend to be heat sensitive and susceptible to microbial contamination. Therefore, it is necessary to use aseptic principles from initial manufacturing steps. It is also important to make consistent products during manufacturing process and should be guaranteed the quality, safety, and efficacy during the validity period.
저자
Ho Jung OH [ Blood Products Division, Korea Food &Drug Administration ]
한국생물공학회 [The Korean Society for Biotechnology and Bioengineering]
설립연도
1984
분야
공학>생물공학
소개
이 법인은 생물 공학의 발전과 보급에 이바지하고, 회원 상호 간의 연구 협력과 친목을 도모함을 목적으로 한다
1. 생물공학 분야의 발전을 위한 연구 협력
2. 생물공학의 실용화를 촉진시키기 위한 산학 협동
3. 학술연구 발표회, 강연회, 연수회 등 학술활동의 개최
4. 국,영문 학술지,소식지,학술회의 Proceedings 및 학술도서의 발간
5. 생물공학 발전을 위한 정책 건의
6. 기타 국제 교류 등 본 학회의 목적 달성을 위한 제반 활동